Detailed information for compound 1729988

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 302.28 | Formula: C19H10O4
  • H donors: 0 H acceptors: 2 LogP: 3.96 Rotable bonds: 0
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C1OC2(c3c1cccc3)Oc1c(C2=O)ccc2c1cccc2
  • InChi: 1S/C19H10O4/c20-17-14-10-9-11-5-1-2-6-12(11)16(14)22-19(17)15-8-4-3-7-13(15)18(21)23-19/h1-10H
  • InChiKey: PYOZRJLJBNCTJF-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma cruzi cyclin 6, putative 0.0209 0.061 1
Echinococcus granulosus cyclin B 0.0209 0.061 0.1917
Giardia lamblia Cyclin A 0.0151 0.0151 0.1756
Echinococcus multilocularis cyclins 0.0151 0.0151 0.0337
Entamoeba histolytica cyclin, putative 0.0151 0.0151 0.1756
Toxoplasma gondii cell-cycle-associated protein kinase CDK, putative 0.0139 0.0053 0.5
Trypanosoma brucei mitotic cyclin 6 0.0209 0.061 1
Entamoeba histolytica cyclin, putative 0.0209 0.061 1
Trichomonas vaginalis cyclins, putative 0.0209 0.061 1
Trichomonas vaginalis cyclin B3, putative 0.0151 0.0151 0.1756
Trichomonas vaginalis cyclin B, putative 0.0209 0.061 1
Echinococcus granulosus cyclin B3 1 0.0151 0.0151 0.0337
Schistosoma mansoni cyclin B3 0.0151 0.0151 0.0098
Trichomonas vaginalis cyclin B, putative 0.0209 0.061 1
Trichomonas vaginalis cyclin D, putative 0.0151 0.0151 0.1756
Schistosoma mansoni cyclin d 0.0504 0.2957 0.2919
Echinococcus multilocularis cyclins 0.0151 0.0151 0.0337
Trypanosoma cruzi cyclin, putative 0.0209 0.061 1
Loa Loa (eye worm) CMGC/CDK/CDK5 protein kinase 0.0139 0.0053 0.0053
Brugia malayi Cyclin, N-terminal domain containing protein 0.0209 0.061 0.056
Giardia lamblia Hypothetical protein 0.0151 0.0151 0.1756
Echinococcus multilocularis cyclins 0.0151 0.0151 0.0337
Echinococcus granulosus G1:S specific cyclin D1 0.0504 0.2957 1
Loa Loa (eye worm) hypothetical protein 0.0504 0.2957 0.2957
Giardia lamblia G2/mitotic-specific cyclin B 0.0209 0.061 1
Leishmania major cyclin 0.0209 0.061 1
Echinococcus multilocularis cyclins 0.0151 0.0151 0.0337
Echinococcus granulosus G2:mitotic specific cyclin B3 0.0151 0.0151 0.0337
Echinococcus multilocularis G2:mitotic specific cyclin B3 0.0151 0.0151 0.0337
Loa Loa (eye worm) CMGC/CDK/CDC2 protein kinase 0.0139 0.0053 0.0053
Loa Loa (eye worm) hypothetical protein 0.0209 0.061 0.061
Leishmania major CYC2-like cyclin, putative,cyclin 6, putative 0.0209 0.061 1
Echinococcus multilocularis cyclin B3 1 0.0151 0.0151 0.0337
Loa Loa (eye worm) cyclin domain-containing protein 0.0151 0.0151 0.0151
Echinococcus granulosus cyclin b3 0.0151 0.0151 0.0337
Entamoeba histolytica cyclin family protein 0.0151 0.0151 0.1756
Echinococcus multilocularis cyclin B 0.0209 0.061 0.1917
Echinococcus multilocularis cyclins 0.0151 0.0151 0.0337
Brugia malayi Cyclin, N-terminal domain containing protein 0.0151 0.0151 0.0098
Schistosoma mansoni cyclins 0.0151 0.0151 0.0098
Loa Loa (eye worm) hypothetical protein 0.0467 0.2666 0.2666
Trichomonas vaginalis cyclin D, putative 0.0151 0.0151 0.1756
Echinococcus multilocularis G1:S specific cyclin D1 0.0504 0.2957 1
Plasmodium falciparum cyclin 0.0151 0.0151 1
Trichomonas vaginalis conserved hypothetical protein 0.0151 0.0151 0.1756
Trichomonas vaginalis cyclin B, putative 0.0209 0.061 1
Loa Loa (eye worm) CMGC/CDK/CDC2 protein kinase 0.0139 0.0053 0.0053
Echinococcus granulosus cyclins 0.0151 0.0151 0.0337
Echinococcus multilocularis cyclin b3 0.0151 0.0151 0.0337
Brugia malayi Cyclin, N-terminal domain containing protein 0.0209 0.061 0.056
Trichomonas vaginalis cyclin A, putative 0.0209 0.061 1
Trichomonas vaginalis cyclins, putative 0.0151 0.0151 0.1756
Trypanosoma cruzi cyclin, putative 0.0209 0.061 1
Trichomonas vaginalis cyclin B, putative 0.0151 0.0151 0.1756
Trichomonas vaginalis cyclin B, putative 0.0209 0.061 1
Plasmodium vivax protein kinase Crk2 0.0139 0.0053 0.5
Echinococcus multilocularis cyclins 0.0151 0.0151 0.0337
Trichomonas vaginalis cyclins, putative 0.0209 0.061 1
Entamoeba histolytica cyclin family protein 0.0151 0.0151 0.1756
Echinococcus granulosus cyclins 0.0151 0.0151 0.0337
Loa Loa (eye worm) hypothetical protein 0.0209 0.061 0.061
Trichomonas vaginalis cyclins, putative 0.0209 0.061 1
Schistosoma mansoni cyclin B 0.0209 0.061 0.056
Trypanosoma cruzi CYC2-like cyclin, putative 0.0209 0.061 1
Brugia malayi Cyclin, N-terminal domain containing protein 0.0504 0.2957 0.2919
Echinococcus granulosus cyclins 0.0151 0.0151 0.0337
Echinococcus multilocularis cyclins 0.0151 0.0151 0.0337
Onchocerca volvulus 0.0209 0.061 0.5
Echinococcus granulosus cyclins 0.0151 0.0151 0.0337
Trichomonas vaginalis cyclins, putative 0.0209 0.061 1
Echinococcus granulosus cyclins 0.0151 0.0151 0.0337

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.